1 / 1

19%

VEH. AAL-R. i.t. i.p. i.t. (0.1 mg/kg). i.p. (0.1 mg/kg). i.p. (0.3 mg/kg). 19%. 25%. 7%. 22%. 25%. Thy1.1. 31%. 18%. 32%. 33%. 37%. CD25. CD8.

gale
Download Presentation

19%

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. VEH AAL-R i.t. i.p. i.t. (0.1 mg/kg) i.p. (0.1 mg/kg) i.p. (0.3 mg/kg) 19% 25% 7% 22% 25% Thy1.1 31% 18% 32% 33% 37% CD25 CD8 Supplementary Figure 1. Mice were adoptively transferred with 5x104 Thy1.1+ GP33/CD8+ T cells. On the following day, mice were inoculated i.n. with 1x105 PFU of FLU-LCMV and instilled with VEH or AAL-R (0.1 or 0.3 mg/kg) either i.t. or i.p. one hpi. Six days later, lungs were processed to a single cell suspension and analyzed by flow cytometry. Percentages of Thy1.1+CD8+ T cells and CD25+CD8+ T cells are depicted on scattergrams. Shown are representative samples of 3-6 different specimens.

More Related